tradingkey.logo

Surmodics Inc

SRDX
26.790USD
+0.370+1.40%
Fechamento 11/07, 16:00ETCotações atrasadas em 15 min
383.04MValor de mercado
PerdaP/L TTM

Mais detalhes de Surmodics Inc Empresa

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.

Informações de Surmodics Inc

Código da empresaSRDX
Nome da EmpresaSurmodics Inc
Data de listagemMar 04, 1998
CEOMr. Gary R. Maharaj
Número de funcionários389
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 04
Endereço9924 W 74th St
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal55344
Telefone19525007000
Sitehttps://www.surmodics.com/
Código da empresaSRDX
Data de listagemMar 04, 1998
CEOMr. Gary R. Maharaj

Executivos da empresa Surmodics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%
Mr. Jose H. Bedoya
Mr. Jose H. Bedoya
Independent Director
Independent Director
30.01K
+3.63%
Mr. Gordon S. Weber, J.D.
Mr. Gordon S. Weber, J.D.
Senior Vice President - Legal, General Counsel, Secretary
Senior Vice President - Legal, General Counsel, Secretary
21.04K
-1.49%
Ms. Lisa Wipperman Heine
Ms. Lisa Wipperman Heine
Independent Director
Independent Director
13.98K
+3.90%
Ms. Teryl L.W. Sides
Ms. Teryl L.W. Sides
Senior Vice President, President - Vascular Interventions
Senior Vice President, President - Vascular Interventions
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gary R. Maharaj
Mr. Gary R. Maharaj
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
192.06K
-2.07%
Mr. Timothy J. Arens
Mr. Timothy J. Arens
Chief Financial Officer, Senior Vice President - Finance and Information Technology
Chief Financial Officer, Senior Vice President - Finance and Information Technology
67.30K
-1.84%
Mr. Joseph J. Stich
Mr. Joseph J. Stich
Senior Vice President of Human Resources, President - In Vitro Diagnostics
Senior Vice President of Human Resources, President - In Vitro Diagnostics
59.53K
-1.71%
Mr. Charles W. Olson
Mr. Charles W. Olson
Senior Vice President, President - Medical Device Coatings
Senior Vice President, President - Medical Device Coatings
52.28K
-1.80%
Dr. David R. Dantzker, M.D.
Dr. David R. Dantzker, M.D.
Independent Director
Independent Director
40.18K
+2.71%
Ms. Susan E. (Sue) Knight
Ms. Susan E. (Sue) Knight
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
37.24K
+5.95%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Domestic
104.64M
83.00%
Foreign
21.43M
17.00%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.13%
AllianceBernstein L.P.
5.95%
The Vanguard Group, Inc.
5.66%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.22%
Outro
70.52%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.13%
AllianceBernstein L.P.
5.95%
The Vanguard Group, Inc.
5.66%
Soleus Capital Management, L.P.
5.52%
Gabelli Funds, LLC
5.22%
Outro
70.52%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
39.31%
Investment Advisor
24.73%
Hedge Fund
22.33%
Research Firm
4.06%
Individual Investor
3.88%
Bank and Trust
0.51%
Sovereign Wealth Fund
0.22%
Pension Fund
0.09%
Insurance Company
0.03%
Outro
4.84%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
312
12.95M
90.59%
-4.14M
2025Q2
321
12.64M
88.41%
-4.03M
2025Q1
343
12.58M
88.00%
-4.09M
2024Q4
362
12.66M
88.58%
-3.97M
2024Q3
348
12.66M
88.74%
-3.48M
2024Q2
329
13.91M
98.26%
-1.49M
2024Q1
308
13.31M
93.49%
-1.66M
2023Q4
311
13.68M
96.13%
-630.83K
2023Q3
314
12.98M
91.82%
-1.55M
2023Q2
312
12.97M
91.74%
-1.29M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
1.02M
7.13%
-27.06K
-2.58%
Jun 30, 2025
AllianceBernstein L.P.
850.47K
5.95%
+1.12K
+0.13%
Jun 30, 2025
The Vanguard Group, Inc.
810.18K
5.67%
+11.51K
+1.44%
Jun 30, 2025
Soleus Capital Management, L.P.
789.06K
5.52%
--
--
Jun 30, 2025
Gabelli Funds, LLC
745.83K
5.22%
+26.83K
+3.73%
Jun 30, 2025
Trium Capital LLP
716.78K
5.01%
+716.78K
--
Jul 11, 2025
UBS Financial Services, Inc.
422.72K
2.96%
+356.98K
+543.00%
Jun 30, 2025
Hudson Bay Capital Management LP
400.00K
2.8%
-64.97K
-13.97%
Jun 30, 2025
Qube Research & Technologies Ltd
393.98K
2.76%
+4.80K
+1.23%
Jun 30, 2025
Readystate Asset Management LP
433.61K
3.03%
+433.61K
--
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
First Trust Merger Arbitrage ETF
4.36%
SPDR S&P Health Care Equipment ETF
0.45%
Inspire Small/Mid Cap ESG ETF
0.19%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
iShares Micro-Cap ETF
0.08%
iShares U.S. Medical Devices ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.05%
iShares Russell 2000 Growth ETF
0.03%
ProShares Hedge Replication ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.02%
Ver Mais
First Trust Merger Arbitrage ETF
Proporção4.36%
SPDR S&P Health Care Equipment ETF
Proporção0.45%
Inspire Small/Mid Cap ESG ETF
Proporção0.19%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.08%
iShares Micro-Cap ETF
Proporção0.08%
iShares U.S. Medical Devices ETF
Proporção0.05%
Franklin US Small Cap Multifactor Index ETF
Proporção0.05%
iShares Russell 2000 Growth ETF
Proporção0.03%
ProShares Hedge Replication ETF
Proporção0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporção0.02%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI